{"nct_id":"NCT01842451","title":"A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis C","status":"COMPLETED","status_verified_date":"2015-11","start_date":"2013-06","start_date_type":null,"primary_completion_date":"2014-05","primary_completion_date_type":"ACTUAL","completion_date":"2014-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["VRTX"]}